lung function

April 14, 2016April 14, 2016

Lungs of Children Exposed to Air Pollution Show Diminished Function, Study Reports

News

Air quality in U.S. cities has dramatically improved since the 1990s, but not enough to ensure that children’s lungs are not being damaged by pollution, according to a study in the American ... Read more

April 13, 2016April 19, 2016

Phase 2a Clinical Trial for IPF Drug Launched by Galapagos

Idiopathic Pulmonary Fibrosis, News

Galapagos, a clinical-stage biotech that specializes in the discovery and development of small molecule medicines with novel modes of action, recently initiated an exploratory Phase 2a clinical trial (FLORA) with ... Read more

April 11, 2016April 11, 2016

Segmental Vapor Ablation for Emphysema Improves Patients’ Pulmonary Function, Researchers Find

Emphysema, News

In a new study, researchers investigated whether selective treatment with vapor ablation of the more diseased lobe segments in the lungs led to clinical improvements in patients suffering from severe ... Read more

April 7, 2016April 7, 2016

Study of Roflumilast for COPD Confirms Benefits as Alternative Therapy

COPD, News

Researchers at Sichuan University in China conducted a study to clarify the controversial therapeutic effects of roflumilast in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). The team found that roflumilast led ... Read more

April 4, 2016April 4, 2016

Cystic Fibrosis Patients See Potentially Promising Therapies from Proteostasis Therapeutics

Cystic Fibrosis, News

Proteostasis Therapeutics — a pharmaceutical company that develops small molecule drugs for cystic fibrosis (CF) — recently announced the latest pre-clinical results from its first-in-class genotype-agnostic amplifier and a novel corrector of CFTR ... Read more

March 18, 2016March 23, 2016

Study Finds IPF Patients Should Continue Pirfenidone Use Even as Disease Progresses

Idiopathic Pulmonary Fibrosis, News

An international group of researchers addressed an important clinical question about idiopathic pulmonary fibrosis (IPF) — Should people with IPF continue treatment with pirfenidone (Esbriet) if their disease meaningfully worsens? ... Read more

March 15, 2016March 16, 2016

For IPF Patients, Results Appear Promising in Phase 2 Study from FibroGen’s Investigative Drug

Idiopathic Pulmonary Fibrosis, News

FibroGen recently announced the publication of results from a Phase 2 clinical trial (NCT01262001) in patients with idiopathic pulmonary fibrosis (IPF), testing a 48-week treatment with the company’s investigational drug FG-3019, ... Read more

March 8, 2016March 8, 2016

Allergic Asthma Patients Show Improvement by Adding Spiriva Respimat to Therapy, According to New Analyses of Data

Asthma, News

Boehringer Ingelheim Pharmaceuticals recently announced that adding its soft mist inhaler device Spiriva Respimat to deliver asthma maintenance drugs helps patients with allergic asthma better control their symptoms. The findings were presented at the ... Read more

February 10, 2016February 10, 2016

Lung Function in COPD Patients Shows Promise With STIOLTO RESPIMAT Inhalation Spray

COPD, News

Boehringer Ingelheim Pharmaceuticals announced the publication of promising new data regarding its inhalation spray, STIOLTO RESPIMAT, in the improvement of lung function when compared to therapy with an European formulation combining ... Read more

February 2, 2016February 4, 2016

High-Fiber Diet May Reduce Risk of Lung Disease, Study Says

News

A diet high in fiber may not only protect against diabetes and heart disease, it may also reduce the risk of developing lung disease, according to recent research. The study, “The ... Read more